Anti-inflammatory therapy of dry eye.

Abstract

As tear secretion and tear clearance decrease in the dry eye, an inflammatory response is initiated on the ocular surface that appears to involve both soluble and cellular mediators. Although the traditional approach to treating dry eye is to hydrate and lubricate the ocular surface with artificial tears, symptoms and/or sight-threatening corneal disease may persist in some patients on such aqueous enhancement therapies. In these patients, treatment with anti-inflammatory agents, such as cyclosporin A, corticosteroids, tetracyclines, or autologous serum, may be considered. Results of studies investigating the use of these agents are discussed. During treatment, patients should be conscientiously monitored for adverse effects.

• Authors: Stephen C Pflugfelder
• Journal: The ocular surface (Ocul Surf) Vol. 1 Issue 1 Pg. 31-6 (Jan 2003) ISSN: 1542-0124 [Print] United States
• PMID: 17075627 (Publication Type: Journal Article)